Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ImmunicInc
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ImmunicInc
-
Immunic Therapeutics proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Immunic Therapeutics proslijedio/la je Tweet
Immunic Exercises its Worldwide Exclusive Option to License for IMU-856 with Daiichi Sankyo
@EUdaiichisankyohttps://www.pharmashots.com/25896/immunic-exercises-its-worldwide-exclusive-option-to-license-for-imu-856-with-daiichi-sankyo/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
#IMUX team is heading to#SanFrancisco for#JPMorgan week these days. We are looking forward to an exciting, productive week and lively discussions with scientific, investor and BD experts. https://bit.ly/39YEPYv$IMUXpic.twitter.com/6lVEzVVD2I
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you,
@DDNewsOnline! We wish you a healthy and successful year 2020, too!https://twitter.com/DDNewsOnline/status/1215333263327350784 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic Therapeutics proslijedio/la je Tweet
.
@ImmunicInc exercises option to#license IMU-856 from@DaiichiSankyo; financials undisclosed Modulator of transcriptional regulator of intestinal barrier function to start Ph1#clinicaltrials in H1 2020 https://www.immunic-therapeutics.com/imu856/#gastroenterology#GeneExpression@SpeakLifeScipic.twitter.com/vnEbYQ3tPo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic Therapeutics proslijedio/la je Tweet
In exchange for an upfront fee, Immunic picks up the exclusive rights to market IMU-856 in all countries.https://www.fiercebiotech.com/biotech/immunic-adds-daiichi-gi-med-to-pipeline-phase-1-deck …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great start into the new year: Today, we exercised our option for the exclusive worldwide license to
#IMU856 from@DaiichiSankyo; phase 1 clinical studies to begin in the first half of 2020 https://bit.ly/2QYTolY$IMUX#DaiichiSankyopic.twitter.com/cTnWd98Rte
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy New Year 2020! May the new year bring joy, peace and happiness to you and your beloved ones!pic.twitter.com/6uqw4VrjNx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy Holidays from the entire Immunic team! We wish you a relaxing and reflective holiday season and a peaceful start into the New Year 2020!
$IMUXpic.twitter.com/6ItGmZsI06Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CFO, Sanjay Patel, will present a company overview at the @PiperJaffrayCo 31st Annual Healthcare Conference in
#NewYork today at 12:10 pm EST. https://bit.ly/2sOWuRd$IMUXpic.twitter.com/lBW5ir6ub9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic Therapeutics proslijedio/la je Tweet
Immunic, Inc. präsentiert auf der IBD Innovate Conference der Crohn's and Colitis Foundation erstmal... http://tinyurl.com/vnjch3d
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Hella Kohlhof, our CSO, will present data on
#IMU856, for the first time, at today’s@CrohnsColitisFn IBD Innovate conference, highlighting its potential to revolutionize the treatment of multiple diseases related to intestinal barrier function. https://bit.ly/35ZVcRz$IMUXpic.twitter.com/jaGJb4kGkV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CSO, Dr. Hella Kohlhof, will present, for the first time, data on
#IMU856 at the@CrohnsColitisFn IBD Innovate Conference in#NewYork tomorrow. The presentation will be part of the Small & Large Molecules session at 11:40 am EST. https://bit.ly/2LeOMGk#Crohns#Colitis$IMUXpic.twitter.com/dHea7GWvgV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic Therapeutics proslijedio/la je Tweet
#Crohns &#UC are#invisibleillnesses that can create physical & emotional challenges for patients. We asked the#IBD community what their biggest challenges are that they face while living with IBD. Here's what they had to say.#IBDvisible#CCAwarenessWeekpic.twitter.com/dHDgCoYUNSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic Therapeutics proslijedio/la je Tweet
Jefferies Healthcare Temperature Check: 80% of respondents expect to see M&A increase or stay at same level in 2020 http://ow.ly/RjZ850xfmRA
#JEFHEALTHCARE19pic.twitter.com/NJHvQ1mEZk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic Therapeutics proslijedio/la je Tweet
Immunic, Inc. kündigt Teilnahme an Investorenkonferenzen und wissenschaftlichen Kongressen im Dezemb... http://tinyurl.com/wanr36h
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic, Inc. to Participate in Investor and Scientific Conferences in December:
#PiperJaffray 31st Annual#Healthcare Conference, Crohn's and Colitis Foundation#IBD Innovate Conference: https://bit.ly/2OFJOTW @PiperJaffrayCo@CrohnsColitisFnpic.twitter.com/diJsw0nSdM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immunic Therapeutics proslijedio/la je Tweet
Immunic, Inc. erweitert Board of Directors mit der Ernennung des Biotechnologie-Experten Barclay A. ... http://tinyurl.com/tpqp2wb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CFO, Sanjay Patel, and our IR & Comms Manager, Jessica Breu, are attending
@Jefferies 2019#Healthcare Conference in#London today and tomorrow and are looking forward to hosting 1x1 meetings.$IMUXpic.twitter.com/d1nZ2RKmRP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are very proud to announce the appointment of Barclay A. Phillips, an established
#lifesciences executive, investor and entrepreneur, to our Board of Directors, effective November 14, 2019. Welcome to the team, Buck! https://bit.ly/3314hIb$IMUXpic.twitter.com/TVpOnYzGBg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.